期刊文献+

顺铂在TRAIL/APO-2L致胶质瘤细胞凋亡作用中影响机制的研究 被引量:4

The effects of CDDP on the progress of apoptosis in glioma cell induced by TRAIL/APO-2L
原文传递
导出
摘要 目的探讨TRAIL对胶质瘤细胞凋亡的影响,并进一步研究DNA破坏药物顺铂(CDDP)在与其联合作用诱导细胞凋亡中影响作用的机制。方法行人脑胶质瘤U251细胞株的培养,应用不同浓度TRAIL和CDDP作用于胶质瘤U251细胞,MTT法检测TRAIL和CDDP分别及联合作用于U251细胞后的存活率,并以亚毒剂量的TRAIL和CDDP联合作用后,流式细胞仪检测其凋亡率。Westernblot方法检测CDDP作用前后TRAIL受体DR5表达量的变化。结果MTT结果:在一定时间范围内,随着药物浓度增加,TRAIL和CDDP分别及联合作用皆使胶质瘤U251细胞存活率逐渐降低,其中两者的联合作用效果明显,与分别作用组差异有统计学意义(P<0.01)。亚毒剂量的TRAIL(50ng·ml-1)、CDDP(4μg·ml-1)分别及联合作用人脑胶质瘤U251细胞24h后,存活率分别为:72.43%,75.56%,23.45%。亚毒剂量的TRAIL(50ng·ml-1)、CDDP(4μg·ml-1)单独或联合作用组致胶质瘤细胞凋亡率分别为25.61%、20.59%、62.33%。单独应用组与联合组之间差异有统计学意义(P<0.01)。Westernblot法检测显示:CDDP作用后较作用前DR5表达有明显增高,随CDDP剂量增多,DR5表达量逐渐增加。结论TRAIL和CDDP联合作用能显著增强其对人U251胶质瘤细胞凋亡的诱导,其机制可能与CDDP能上调TRAIL死亡受体DR5的表达有关。 Objective To investigate the effects of TRAIL on apoptosis in human glioma cell line and study the mechanism of CDDP on apoptotic process induced by TRAIL . Methods Different doses of CDDP was added in the media of glioma cells with treatment of different doses of TRAIL, then viability was examined by MTT assay. Afterwards, sub-poisonous dose of TRAIL and CDDP were added into media of glioma cells, the apoptotic percentages of three experimental groups that included the TRAIL, CDDP and TRAIL-CDDP groups were examined by FCM. Western blot assay was used to examine the expression of DR5 with or without CDDP. Results Within a certain time, when the doses of TRAIL and CDDP increased, the viability of U251 glioma cell became lower synchronously. The viability of glioma cells induced by TRAIL, CDDP and TRAIL-CDDP which were 50 ng·ml -1 and 4μg·ml -1and 50 ng·ml -1- 4μg·ml -1 were 72.43% , 75.56% and 23.45%,respectively. The apoptotic percentages of glioma cells induced by TRAIL, CDDP and TRAIL-CDDP were 25.61%,20.59% and 62.33%, respectively. The apoptotic percentages of glioma cells induced by CDDP and TRAIL were significantly lower than that by TRAIL-CDDP(P<0.01). Western blot showed that the expression of DR5 of cells with CDDP was higher than that without CDDP. The expression of DR5 was increased gradually within certain time. Conclusions The apoptosis of glioma cell induced by TRAIL-CDDP was significantly higher than that of cells treated by TRAIL or CDDP solely. The mechanism may be that the expression of DR5 was up-regulated by CDDP.
出处 《中华神经外科杂志》 CSCD 北大核心 2005年第5期274-278,共5页 Chinese Journal of Neurosurgery
基金 山东省卫生厅基金资助(1998CAICJA8)
  • 相关文献

参考文献15

  • 1Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 1995, 3:673-682.
  • 2Walczak H, Krammer PH. The CD95(APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res, 2000, 256:58-66.
  • 3何松青,陈孝平,张万广,王海平,王其.肿瘤坏死因子相关凋亡诱导配体对肝癌耐药细胞株阿霉素化疗敏感性的影响[J].中华肝脏病杂志,2004,12(8):456-459. 被引量:3
  • 4Kagawa S, He C, Cu J, et al. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res, 2001, 61:3330 -3338.
  • 5关良,冯健男,王国华,阙海萍,刘少君.人突变型TRAIL体外诱导脑恶性胶质瘤细胞凋亡的研究[J].中华神经外科杂志,2004,20(4):315-318. 被引量:6
  • 6Pollack I F, Erff M, Ashkenazi A, et al. Direct stimulation of apoptotic signaling by soluble Apo21/tumor necrosis factor-related apoptosis -inducing ligand leads to selective killing of glioma cells.Clin Cancer Res, 2001,7:1362-1369.
  • 7Rohn TA, Wagenknecht B, Roth W, et al. CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release. Oncogene, 2001,20: 4128-4137.
  • 8Kasibhatla S, Brunner T. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF kappa B and AP-1 . Mol Cell, 1998, 1:543-551.
  • 9Meng RD, El-Deiry WS. P53-independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferongamma. Exp Cell Res, 2001,262:154-169.
  • 10Nagane M, Pan G, Weddle J J, et al. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosisinducing ligand in vitro and in vivo. Cancer Res, 2000, 60: 847-853.

二级参考文献18

  • 1Wiley SR,Schooley K,Smolak PJ,et al.Identification and characterization of a new member of the TNF family that induces apoptosis.Immunity,1995,3:673-682.
  • 2Pitti RM,Marsters SA,Ruppert S,et al.Induction of apoptosis by Apo-2 ligand,a new member of the tumor necrosis factor cytokine family.J Biol Chem,1996,271:12687-12690.
  • 3Sheridan JP,Marsters SA,Pitti RM,et al.Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors.Science,1997,277:818-821.
  • 4Ashkenazi A,Dixit VM.Death receptors:signaling and modulation.Science,1998,281:1305-1308.
  • 5Okano H,Shiraki K,Inoue H,et al.Peroxisome proliferator-activated receptor gamma augments tumor necrosis factor family-induced apoptosis in hepatocellular carcinoma.Anticancer Drugs,2002,13:59-65.
  • 6Yamanaka T,Shiraki K,Sugimoto K,et al.Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines.Hepatology,2000,32:482-490.
  • 7Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induced apoptosis. Immunity, 1995, 3: 673-682.
  • 8Walczak H, Miller RE, Ariail K, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med,1999, 5: 157-163.
  • 9Nagane M, Pan G, Weddle JJ, et al. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-induing ligand in vitro and in vivo. Cancer Res, 2000, 60: 84
  • 10Frank S, Kohler U, Schackert G, et al. Expression of TRAIL and its receptors in human brain tumors. Biochem Biophys Res Commun,1999, 257: 454-459.

共引文献37

同被引文献27

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部